Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study Two hundred twenty-eight patients were observed for a median of 62.9 months. By study design, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results